Northrop Grumman Beats on Q2 Earnings & Revenues, Raises '25 EPS View

22.07.25 17:04 Uhr

Werte in diesem Artikel
Aktien

482,90 EUR -0,60 EUR -0,12%

75,50 EUR -0,50 EUR -0,66%

Indizes

6.388,6 PKT 25,3 PKT 0,40%

Northrop Grumman Corporation NOC reported second-quarter 2025 adjusted earnings of $7.11 per share, which beat the Zacks Consensus Estimate of $6.71 by 6%.Including one-time items, the company reported GAAP earnings of $8.15 per share, which improved 28% from the year-ago quarter’s reported number of $6.36.The year-over-year improvement can be attributed to strong segment operating performance and a net after-tax benefit related to the divestiture of the company’s training services business.NOC’s Total SalesNOC’s total sales of $10.35 billion in the second quarter beat the Zacks Consensus Estimate of $10.06 billion by 2.9%. The top line also rose 1.3% from $10.22 billion reported in the year-ago quarter. The improvement can be attributed to higher sales from its Aeronautics Systems, Defense Systems and Mission Systems segments.Northrop Grumman Corporation Price, Consensus and EPS Surprise Northrop Grumman Corporation price-consensus-eps-surprise-chart | Northrop Grumman Corporation QuoteNorthrop Grumman’s Backlog CountThe company’s total backlog was $89.74 billion at the end of the second quarter compared with $92.80 billion at the end of the first quarter of 2025.Our model projected a backlog worth $115.31 billion for the second quarter of 2025.NOC’s Segmental DetailsAeronautics Systems: This segment’s sales of $3.11 billion increased 2% year over year, driven by the higher volume of the B-21 program and the ramp-up of the E-130J TACAMO program.The unit’s operating income totaled $321 million compared with the operating income of $312 million in the second quarter of 2024. Its operating profit margin also improved 10 basis points (bps) to 10.3%.Mission Systems: Sales in this segment increased 14% to $3.16 billion. This was driven by the favorable timing of a restricted award, higher volumes from marine systems, international ground-based radar, advanced technologies and navigation systems programs.The unit’s operating income rose 22% to $441 million. The operating margin expanded 100 bps to 14%.Defense Systems: This segment’s sales jumped 7% year over year to $1.99 billion. The improvement was driven by higher sales from the Sentinel program and military ammunition programs.The unit’s operating income improved 32% year over year to $253 million. The operating margin expanded 240 bps to 12.7%.Space Systems: Sales in this segment declined 12% to $2.65 billion due to the winding down of work on the restricted space and Next Generation Interceptor programs, as well as lower volumes from Space Development Agency satellite programs.The segment’s operating income decreased 8% year over year to $280 million. However, the operating margin expanded 50 bps to 10.6%.Northrop Grumman’s Operational UpdateTotal operating income during the quarter totaled $1.43 billion, reflecting a significant rise from $1.09 billion in the prior-year quarter. This increase was due to higher operating income at Aeronautics Systems, Mission Systems and Defense Systems.NOC’s Financial ConditionNorthrop Grumman’s cash and cash equivalents as of June 30, 2025 totaled $1.90 billion, down from $4.35 billion as of Dec. 31, 2024.Long-term debt (net of the current portion) amounted to $15.16 billion compared with $14.69 billion as of Dec. 31, 2024.Net cash outflow from operating activities totaled $697 million during the first six months of 2025 against cash inflow of $719 million a year ago.Northrop Grumman’s 2025 GuidanceThe company updated its 2025 guidance. NOC now expects its revenues in the range of $42.05-$42.25 billion, narrower than the previous guidance in the band of $42.00-$42.50 billion. The Zacks Consensus Estimate for sales is pegged at $41.98 billion, lower than the company’s newly guided range.NOC now expects adjusted earnings in the band of $25.00-$25.40 per share, higher than its earlier guided band of $24.95-$25.35. The Zacks Consensus Estimate for earnings is pegged at $25.13 per share, below the midpoint of the company’s guided range.Northrop Grumman now projects to generate adjusted free cash flow in the band of $3.05-$3.35 billion, higher from the previous range of $2.85-$3.25 billion.NOC’s Zacks RankNOC currently has a Zacks Rank #4 (Sell). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.A Recent Defense ReleaseAAR Corp. AIR reported fourth-quarter fiscal 2025 adjusted earnings of $1.16 per share, which surpassed the Zacks Consensus Estimate of $1.00 by 16%. The bottom line also improved 31.8% from the year-ago quarter’s level of 88 cents.AAR generated net sales of $754.5 million. The reported figure surpassed the Zacks Consensus Estimate of $691 million by 9.2%. The figure also increased 14.9% from $656.5 million recorded in the year-ago quarter.Upcoming Q1 Defense ReleasesGeneral Dynamics Corporation GD is set to report second-quarter 2025 results on July 23, before market open.The Zacks Consensus Estimate for GD’s earnings is pegged at $3.59 per share. The consensus estimate for its sales is pegged at $12.35 billion, indicating year-over-year growth of 3.1%.The Boeing Company BA is set to report second-quarter 2025 earnings on July 29, before market open.The Zacks Consensus Estimate for BA’s loss is pegged at $1.47 per share. The consensus estimate for its sales is pegged at $21.93 billion, implying year-over-year growth of 30%.Zacks' Research Chief Names "Stock Most Likely to Double"Our team of experts has just released the 5 stocks with the greatest probability of gaining +100% or more in the coming months. Of those 5, Director of Research Sheraz Mian highlights the one stock set to climb highest.This top pick is a little-known satellite-based communications firm. Space is projected to become a trillion dollar industry, and this company's customer base is growing fast. Analysts have forecasted a major revenue breakout in 2025. Of course, all our elite picks aren't winners but this one could far surpass earlier Zacks' Stocks Set to Double like Hims & Hers Health, which shot up +209%.Free: See Our Top Stock And 4 Runners UpWant the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report The Boeing Company (BA): Free Stock Analysis Report Northrop Grumman Corporation (NOC): Free Stock Analysis Report General Dynamics Corporation (GD): Free Stock Analysis Report AAR Corp. (AIR): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

In eigener Sache

Übrigens: Northrop Grumman und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und als Geschenk eine Gratisaktie erhalten.

Ausgewählte Hebelprodukte auf Northrop Grumman

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Northrop Grumman

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Quelle: Zacks

Nachrichten zu Northrop Grumman Corp.

Wer­bung

Analysen zu Northrop Grumman Corp.

DatumRatingAnalyst
29.03.2018Northrop Grumman OverweightBarclays Capital
26.10.2017Northrop Grumman OutperformRBC Capital Markets
12.01.2017Northrop Grumman OutperformRBC Capital Markets
10.11.2016Northrop Grumman OverweightBarclays Capital
06.10.2016Northrop Grumman OutperformRobert W. Baird & Co. Incorporated
DatumRatingAnalyst
29.03.2018Northrop Grumman OverweightBarclays Capital
26.10.2017Northrop Grumman OutperformRBC Capital Markets
12.01.2017Northrop Grumman OutperformRBC Capital Markets
10.11.2016Northrop Grumman OverweightBarclays Capital
06.10.2016Northrop Grumman OutperformRobert W. Baird & Co. Incorporated
DatumRatingAnalyst
19.05.2016Northrop Grumman Sector PerformRBC Capital Markets
02.05.2016Northrop Grumman Equal WeightBarclays Capital
30.04.2015Northrop Grumman NeutralUBS AG
12.02.2015Northrop Grumman Equal WeightBarclays Capital
19.10.2012Northrop Grumman performOppenheimer & Co. Inc.
DatumRatingAnalyst
13.09.2012Northrop Grumman sellUBS AG
14.06.2006Update Northrop Grumman Corp.: UnderperformGoldman Sachs

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Northrop Grumman Corp. nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen